Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Nitrobacter sp. NbAS1

ABSTRACT: Genome sequencing of Nitrobacter sp. NbAS1

PROVIDER: PRJDB5516 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	DRR086901_1.fastq.gz	Fastqsanger.gz
	DRR086901_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

Nitrobacter sp. JJSN

Project description:Nitrobacter sp. JJSN Genome sequencing

| PRJNA1297094 | ENA

Project description:Nitrobacter sp. CN101 genome sequencing

| PRJDB17632 | ENA

Nitrobacter sp. Pearl River02

Project description:Nitrobacter sp. Pearl River02 Genome sequencing

| PRJNA820359 | ENA

Nitrobacter sp.

Project description:Nitrobacter sp. Genome sequencing and assembly

| PRJNA1220033 | ENA

Nitrobacter sp. N1 strain:N1

Project description:Nitrobacter sp. N1 strain:N1 Genome sequencing

| PRJNA820293 | ENA

Nitrobacter sp. NHB1

Project description:Nitrobacter sp. NHB1 Genome sequencing and assembly

| PRJNA1074292 | ENA

Nitrifying bacteria and denitrifying bacteria

Project description:Nitrobacter Genome sequencing and assembly

| PRJNA786295 | ENA

DNA-seq of Halomonas sp. DSM7328 original strain and evolved population in low dissolved oxygen level

Project description:Whole genome sequencing was performed on Halomonas sp. DSM7328 both original strain and evolved population in low dissolved oxygen (DO) level at 0.5% DO. The evolved Halomonas sp. DSM7328 was analysed and compared to the original strain.

2026-04-15 | E-MTAB-15059 | biostudies-arrayexpress

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Nitrobacter winogradskyi strain:Nb-102

Project description:Nitrobacter winogradskyi Nb-102 genome sequencing

| PRJNA708441 | ENA